Atul Deodhar Selected Research

ixekizumab

11/2022	Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging.
10/2022	Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
10/2022	Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
9/2021	Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks.
3/2021	Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial.
12/2020	Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks.
1/2020	Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W).
1/2020	Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
10/2019	Ixekizumab for treating ankylosing spondylitis.
1/2019	Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atul Deodhar Research Topics

Disease

65	Ankylosing Spondylitis 12/2022 - 09/2008
27	Axial Spondyloarthritis 11/2022 - 06/2014
23	Psoriatic Arthritis 11/2022 - 10/2013
13	Necrosis 11/2022 - 01/2008
13	Non-Radiographic Axial Spondyloarthritis 09/2022 - 01/2016
12	Inflammation (Inflammations) 11/2022 - 07/2013
12	Rheumatoid Arthritis 01/2022 - 08/2002
10	Infections 08/2022 - 08/2008
10	Arthritis (Polyarthritis) 03/2021 - 06/2014
9	Pain (Aches) 11/2022 - 12/2014
9	Fatigue 11/2022 - 08/2009
7	Sacroiliitis 09/2022 - 01/2016
7	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 10/2014
4	Back Pain (Backache) 01/2022 - 01/2016
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 10/2014
3	Neoplasms (Cancer) 11/2022 - 01/2018
3	Chronic Disease (Chronic Diseases) 01/2022 - 01/2021
3	Uveitis 03/2021 - 10/2014
3	Nasopharyngitis 01/2020 - 01/2018
2	Ankylosis 12/2022 - 12/2017
2	COVID-19 09/2022 - 08/2022
2	Opportunistic Infections (Opportunistic Infection) 01/2022 - 01/2021
2	Candidiasis (Moniliasis) 12/2018 - 12/2015
2	Crohn Disease (Crohn's Disease) 12/2018 - 12/2015
2	Spondylarthropathies 01/2018 - 12/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 10/2014
2	Iritis 02/2016 - 02/2016
2	Vasculitis (Vasculitides) 08/2014 - 08/2002
2	Fibromyalgia (Fibrositis) 04/2009 - 05/2002
1	Venous Thromboembolism 11/2022
1	Disease Progression 08/2022
1	Rheumatic Diseases (Rheumatism) 08/2022
1	Demyelinating Diseases (Demyelinating Disease) 03/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Chickenpox 11/2021
1	Herpes Zoster 01/2021
1	Anterior Uveitis 01/2021
1	Hypoalbuminemia 10/2020
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 10/2020
1	Edema (Dropsy) 10/2020
1	Heart Failure 01/2020

Drug/Important Bio-Agent (IBA)

22	Tumor Necrosis Factor InhibitorsIBA 11/2022 - 06/2014
21	secukinumabIBA 04/2022 - 01/2015
18	golimumab FDA Link 12/2022 - 09/2010
18	C-Reactive ProteinIBA 11/2022 - 08/2009
17	Biological ProductsIBA 11/2022 - 05/2012
15	Antirheumatic Agents (DMARD)IBA 11/2022 - 01/2015
13	Monoclonal AntibodiesIBA 09/2021 - 06/2014
12	ixekizumabIBA 11/2022 - 01/2018
12	Interleukin-17 (Interleukin 17)IBA 11/2022 - 10/2014
9	guselkumabIBA 11/2022 - 01/2018
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 01/2008
8	Certolizumab Pegol FDA Link 09/2022 - 01/2016
7	Adalimumab (Humira)FDA Link 11/2022 - 01/2008
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 02/2016
7	Etanercept (Enbrel)FDA Link 01/2022 - 08/2002
5	upadacitinibIBA 11/2022 - 12/2019
5	Interleukin-23 (Interleukin 23)IBA 01/2022 - 01/2018
5	Infliximab (Remicade)FDA Link 11/2021 - 01/2008
5	Rituximab (Mabthera)FDA Link 05/2017 - 08/2008
4	Janus Kinase InhibitorsIBA 11/2022 - 08/2017
4	InterleukinsIBA 04/2022 - 01/2018
4	CytokinesIBA 01/2022 - 01/2008
4	tofacitinibIBA 01/2022 - 08/2017
4	Pharmaceutical PreparationsIBA 06/2020 - 10/2014
3	bimekizumabIBA 09/2022 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2009
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 08/2002
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2021 - 06/2011
3	belimumabIBA 10/2020 - 10/2014
3	GlucocorticoidsIBA 01/2019 - 02/2016
2	VaccinesIBA 08/2022 - 11/2021
2	GLPG0634IBA 01/2022 - 12/2018
2	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2022 - 03/2021
2	Janus KinasesIBA 01/2022 - 01/2022
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 08/2002
2	Interleukin-23 Subunit p19IBA 01/2021 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2013
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2019 - 10/2019
2	Ustekinumab (CNTO 1275)FDA Link 01/2019 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 05/2012
2	Hemoglobins (Hemoglobin)IBA 12/2016 - 08/2009
2	Prednisone (Sone)FDA LinkGeneric 10/2014 - 08/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	InterferonsIBA 01/2022
1	Herpes Zoster VaccineIBA 11/2021
1	Opioid Analgesics (Opioids)IBA 04/2020
1	apremilastIBA 01/2020

Therapy/Procedure

24	Therapeutics 08/2022 - 08/2002
4	Biological Therapy 11/2022 - 05/2012
3	Physical Therapy Modalities (Physical Therapy Technique) 03/2019 - 02/2016
2	Arthroplasty 02/2016 - 02/2016
2	Subcutaneous Injections 12/2012 - 05/2012
1	Drug Therapy (Chemotherapy) 01/2022
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Immunomodulation 11/2021